KLYDEO owner Contact Information online
from GENZYME CORPORATION
KLYDEO
US serial number:85066170
Application filling date:Jun. 18, 2010
Register:Principal
Mark type:Trademark
Status:Abandoned after publication because applicant filed an express abandonment. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Jan. 19, 2011
Publication date:Nov. 16, 2010
Abandoned date:Jan. 18, 2011
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: Pharmaceutical preparations for the treatment of cardiovascular disorders and cholesterol reduction
International Class(es): 005- Primary Class
U.S Class(es): 006,018,044,046,051,052
Class Status: ABANDONED
Basis: 1(b)
Services:Pharmaceutical preparations for the treatment of cardiovascular disorders and cholesterol reduction
Current owner owner name:GENZYME CORPORATION
Current owner owner address:500 Kendall Street
Cambridge,
MASSACHUSETTS
UNITED STATES
02142
Current owner legal entity type:CORPORATION
Current owner state or country:MASSACHUSETTS
Attorney name:Richard D. Allison
Attorney email:linda.leontie@genzyme.com
Attorney email authorized:Yes
Correspondent name address:RICHARD D. ALLISON
GENZYME CORPORATION
15 PLEASANT STREET CONNEC
FRAMINGHAM,
MASSACHUSETTS
UNITED STATES
01701-5457
Correspondent phone:508-270-2583
Correspondent email:linda.leontie@genzyme.com
Correspondent fax:508-872-5415
Correspondent email authorized:Yes
Trademark staff tm attorney:YARD, JOHN S
Trademark staff law office assigned KLYDEO:LAW OFFICE 115
Latest trademarks
Popular owners
Glaxo Group Limited (173) Novartis AG (131) JOHNSON & JOHNSON (127) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) SANOFI (41) Wyeth LLC (41) Pfizer Inc. (39) Forest Laboratories, Inc. (34) Bristol-Myers Squibb Company (33) S. C. Johnson & Son, Inc. (31) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
Nov. 16, 2010 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Mar. 29, 2011 Apr. 19, 2011 Apr. 12, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010 Apr. 05, 2011Similar brands
